Abstract
Studies on an esterase derived from partially purified preparations of the first component of complement are described. The esterase hydrolyzed certain synthetic amino acid esters, among which N-acetyl-L-tyrosine ethyl ester was most susceptible. This was hydrolyzed maximally between pH 7.5 and 8.2, and at 41°C. The esterase could not be identified with other previously described hydrolytic enzymes. An esterase with similar properties could also be eluted from antigen-antibody aggregates which had been treated with serum. Human serum contained a heat-labile inhibitor of the esterase which could not be identified with any of the known components of complement. The esterase was also inhibited by certain reducing agents. The experiments described support the early hypothesis that complement exerts its action enzymatically, but the physiological role of the esterase derived from preparations of complement is not yet clear.
Full Text
The Full Text of this article is available as a PDF (958.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BECKER E. L. Inhibition of complement activity by di-isopropyl fluorophosphate. Nature. 1955 Dec 3;176(4492):1073–1073. doi: 10.1038/1761073a0. [DOI] [PubMed] [Google Scholar]
- Bier O. G., Leyton G., Mayer M. M., Heidelberger M. A COMPARISON OF HUMAN AND GUINEA PIG COMPLEMENTS AND THEIR COMPONENT FRACTIONS. J Exp Med. 1945 May 1;81(5):449–468. doi: 10.1084/jem.81.5.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- CARTER J. R., WARNER E. D. Importance of the disulfide (-S-S-) linkage in the blood-clotting mechanism. Am J Physiol. 1953 Apr;173(1):109–114. doi: 10.1152/ajplegacy.1953.173.1.109. [DOI] [PubMed] [Google Scholar]
- HESTRIN S. The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application. J Biol Chem. 1949 Aug;180(1):249–261. [PubMed] [Google Scholar]
- Jobling J. W., Petersen W., Eggstein A. A. THE MECHANISM OF ANAPHYLACTIC SHOCK : STUDIES ON FERMENT ACTION. XXIII. J Exp Med. 1915 Oct 1;22(4):401–417. doi: 10.1084/jem.22.4.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LEPOW I. H., RATNOFF O. D., PILLEMER L. Elution of an esterase from antigen-antibody aggregates treated with human complement. Proc Soc Exp Biol Med. 1956 May;92(1):111–114. doi: 10.3181/00379727-92-22401. [DOI] [PubMed] [Google Scholar]
- LEPOW I. H., RATNOFF O. D., ROSEN F. S., PILLEMER L. Observations on a pro-esterase associated with partially purified first component of human complement (C'1). Proc Soc Exp Biol Med. 1956 May;92(1):32–37. doi: 10.3181/00379727-92-22376. [DOI] [PubMed] [Google Scholar]
- LEPOW I. H., WURZ L., RATNOFF O. D., PILLEMER L. Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C'1 and the role of Ca++. J Immunol. 1954 Sep;73(3):146–158. [PubMed] [Google Scholar]
- LEVINE L. Inhibition of immune hemolysis by diisopropyl fluorophosphate. Biochim Biophys Acta. 1955 Oct;18(2):283–284. doi: 10.1016/0006-3002(55)90069-x. [DOI] [PubMed] [Google Scholar]
- PILLEMER L., BLUM L., LEPOW I. H., ROSS O. A., TODD E. W., WARDLAW A. C. The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena. Science. 1954 Aug 20;120(3112):279–285. doi: 10.1126/science.120.3112.279. [DOI] [PubMed] [Google Scholar]
- PILLEMER L., RATNOFF O. D., BLUM L., LEPOW I. H. The inactivation of complement and its components by plasmin. J Exp Med. 1953 Apr;97(4):573–589. doi: 10.1084/jem.97.4.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Swyer G. I., Emmens C. W. A modified method for the viscosimetric assay of hyaluronidase. Biochem J. 1947;41(1):29–34. doi: 10.1042/bj0410029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- TROLL W., SHERRY S., WACHMAN J. The action of plasmin on synthetic substrates. J Biol Chem. 1954 May;208(1):85–93. [PubMed] [Google Scholar]